TreeWAS – Variant ID: rs9303542

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
T36-T50 Poisoning by drugs, medicaments and biological substances	0.863	0.137	0.000
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs	0.857	0.143	0.000
T42.6 Other antiepileptic and sedative-hypnotic drugs	0.842	0.158	0.000
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.822	0.178	0.000
T46 Poisoning by agents primarily affecting the cardiovascular system	0.812	0.188	0.000
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics	0.803	0.197	0.000
T47.1 Other antacids and anti-gastric-secretion drugs	0.755	0.245	0.000
T44 Poisoning by drugs primarily affecting the autonomic nervous system	0.747	0.253	0.000
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]	0.745	0.255	0.000
T43 Poisoning by psychotropic drugs, not elsewhere classified	0.743	0.257	0.000
T36 Poisoning by systemic antibiotics	0.734	0.266	0.000
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances	0.714	0.286	0.000
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified	0.710	0.290	0.000
T42.4 Benzodiazepines	0.705	0.295	0.000
T47.4 Other laxatives	0.696	0.304	0.000
T46.4 Angiotensin-converting-enzyme inhibitors	0.694	0.306	0.000
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.683	0.317	0.000
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.680	0.320	0.000
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified	0.680	0.320	0.000
T42.1 Iminostilbenes	0.674	0.326	0.000
T43.2 Other and unspecified antidepressants	0.672	0.328	0.000
T46.3 Coronary vasodilators, not elsewhere classified	0.668	0.332	0.000
T43.0 Tricyclic and tetracyclic antidepressants	0.664	0.336	0.000
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system	0.661	0.339	0.000
T46.1 Calcium-channel blockers	0.638	0.362	0.000
T40.6 Other and unspecified narcotics	0.628	0.372	0.000
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified	0.627	0.373	0.000
T46.2 Other antidysrhythmic drugs, not elsewhere classified	0.621	0.379	0.000
T47.6 Antidiarrhoeal drugs	0.620	0.380	0.000
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs	0.619	0.381	0.000
T41 Poisoning by anaesthetics and therapeutic gases	0.619	0.381	0.000
T39.1 4-Aminophenol derivatives	0.619	0.381	0.000
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants	0.615	0.385	0.000
T42.5 Mixed antiepileptics, not elsewhere classified	0.615	0.385	0.000
T42.3 Barbiturates	0.615	0.385	0.000
T42.2 Succinimides and oxazolidinediones	0.615	0.385	0.000
T36.0 Penicillins	0.608	0.392	0.000
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified	0.608	0.392	0.000
T47.0 Histamine H(2)-receptor antagonists	0.603	0.397	0.000
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified	0.598	0.402	0.000
T42.0 Hydantoin derivatives	0.595	0.405	0.000
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.589	0.411	0.000
T47.8 Other agents primarily affecting the gastro-intestinal system	0.589	0.411	0.000
T47.7 Emetics	0.589	0.411	0.000
T47.5 Digestants	0.589	0.411	0.000
T47.3 Saline and osmotic laxatives	0.589	0.411	0.000
T47.2 Stimulant laxatives	0.589	0.411	0.000
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified	0.587	0.413	0.000
T46.9 Other and unspecified agents primarily affecting the cardiovascular system	0.582	0.418	0.000
T46.8 Antivaricose drugs, including sclerosing agents	0.582	0.418	0.000
T46.7 Peripheral vasodilators	0.582	0.418	0.000
T46.0 Cardiac-stimulant glycosides and drugs of similar action	0.582	0.418	0.000
T50.4 Drugs affecting uric acid metabolism	0.580	0.420	0.000
T39.4 Antirheumatics, not elsewhere classified	0.576	0.424	0.000
T39.2 Pyrazolone derivatives	0.576	0.424	0.000
T40.2 Other opioids	0.570	0.430	0.000
T40.1 Heroin	0.570	0.430	0.000
T39.0 Salicylates	0.567	0.433	0.000
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.565	0.435	0.000
T36.4 Tetracyclines	0.561	0.439	0.000
T37 Poisoning by other systemic anti-infectives and antiparasitics	0.560	0.440	0.000
T50.6 Antidotes and chelating agents, not elsewhere classified	0.557	0.443	0.000
T40.5 Cocaine	0.555	0.445	0.000
T36.3 Macrolides	0.549	0.451	0.000
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified	0.536	0.464	0.000
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.536	0.464	0.000
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.536	0.464	0.000
T44.2 Ganglionic blocking drugs, not elsewhere classified	0.536	0.464	0.000
T44.1 Other parasympathomimetics [cholinergics]	0.536	0.464	0.000
T44.0 Anticholinesterase agents	0.536	0.464	0.000
T40.9 Other and unspecified psychodysleptics [hallucinogens]	0.534	0.466	0.000
T40.8 Lysergide [LSD]	0.534	0.466	0.000
T40.7 Cannabis (derivatives)	0.534	0.466	0.000
T40.3 Methadone	0.534	0.466	0.000
T40.0 Opium	0.534	0.466	0.000
T43.9 Psychotropic drug, unspecified	0.532	0.467	0.000
T43.8 Other psychotropic drugs, not elsewhere classified	0.532	0.467	0.000
T43.1 Monoamine-oxidase-inhibitor antidepressants	0.532	0.467	0.000
T43.5 Other and unspecified antipsychotics and neuroleptics	0.532	0.468	0.000
T50.9 Other and unspecified drugs, medicaments and biological substances	0.531	0.469	0.000
T36.9 Systemic antibiotic, unspecified	0.526	0.474	0.000
T36.8 Other systemic antibiotics	0.526	0.474	0.000
T36.7 Antifungal antibiotics, systemically used	0.526	0.474	0.000
T36.6 Rifamycins	0.526	0.474	0.000
T36.5 Aminoglycosides	0.526	0.474	0.000
T36.2 Chloramphenicol group	0.526	0.474	0.000
T36.1 Cefalosporins and other Beta-lactam antibiotics	0.526	0.474	0.000
T48.6 Antiasthmatics, not elsewhere classified	0.516	0.484	0.000
T43.4 Butyrophenone and thioxanthene neuroleptics	0.514	0.486	0.000
T50.8 Diagnostic agents	0.512	0.488	0.000
T50.7 Analeptics and opioid receptor antagonists	0.512	0.488	0.000
T50.5 Appetite depressants	0.512	0.488	0.000
T50.3 Electrolytic, caloric and water-balance agents	0.512	0.488	0.000
T50.1 Loop [high-ceiling] diuretics	0.512	0.488	0.000
T50.0 Mineralocorticoids and their antagonists	0.512	0.488	0.000
T44.9 Other and unspecified drugs primarily affecting the nervous system	0.512	0.488	0.000
T40.4 Other synthetic narcotics	0.501	0.499	0.000
T46.5 Other antihypertensive drugs, not elsewhere classified	0.488	0.512	0.000
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics	0.486	0.514	0.000
T48.7 Other and unspecified agents primarily acting on the respiratory system	0.474	0.526	0.000
T48.5 Anti-common-cold drugs	0.474	0.526	0.000
T48.4 Expectorants	0.474	0.526	0.000
T48.3 Antitussives	0.474	0.526	0.000
T48.2 Other and unspecified agents primarily acting on muscles	0.474	0.526	0.000
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.474	0.526	0.000
T48.0 Oxytocic drugs	0.474	0.526	0.000
T41.5 Therapeutic gases	0.444	0.556	0.000
T41.4 Anaesthetic, unspecified	0.444	0.556	0.000
T41.3 Local anaesthetics	0.444	0.556	0.000
T41.2 Other and unspecified general anaesthetics	0.444	0.556	0.000
T41.1 Intravenous anaesthetics	0.444	0.556	0.000
T41.0 Inhaled anaesthetics	0.444	0.556	0.000
T49.9 Topical agent, unspecified	0.444	0.556	0.000
T49.8 Other topical agents	0.444	0.556	0.000
T49.7 Dental drugs, topically applied	0.444	0.556	0.000
T49.6 Otorhinolaryngological drugs and preparations	0.444	0.556	0.000
T49.5 Ophthalmological drugs and preparations	0.444	0.556	0.000
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.444	0.556	0.000
T49.3 Emollients, demulcents and protectants	0.444	0.556	0.000
T49.2 Local astringents and local detergents	0.444	0.556	0.000
T49.1 Antipruritics	0.444	0.556	0.000
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.444	0.556	0.000
T38.1 Thyroid hormones and substitutes	0.439	0.561	0.000
T38.8 Other and unspecified hormones and their synthetic substitutes	0.409	0.591	0.000
T38.9 Other and unspecified hormone antagonists	0.405	0.595	0.000
T38.7 Androgens and anabolic congeners	0.405	0.595	0.000
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified	0.405	0.595	0.000
T38.5 Other oestrogens and progestogens	0.405	0.595	0.000
T38.4 Oral contraceptives	0.405	0.595	0.000
T38.2 Antithyroid drugs	0.405	0.595	0.000
T38.0 Glucocorticoids and synthetic analogues	0.405	0.595	0.000
T37.9 Systemic anti-infective and antiparasitic, unspecified	0.401	0.598	0.000
T37.5 Antiviral drugs	0.401	0.598	0.000
T37.4 Anthelminthics	0.401	0.598	0.000
T37.3 Other antiprotozoal drugs	0.401	0.598	0.000
T37.2 Antimalarials and drugs acting on other blood protozoa	0.401	0.598	0.000
T37.1 Antimycobacterial drugs	0.401	0.598	0.000
T37.0 Sulphonamides	0.401	0.598	0.000
T43.3 Phenothiazine antipsychotics and neuroleptics	0.382	0.618	0.000
T43.6 Psychostimulants with abuse potential	0.375	0.625	0.000
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified	0.370	0.630	0.000
T37.8 Other specified systemic anti-infectives and antiparasitics	0.342	0.657	0.000
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.288	0.712	0.000
T45.0 Antiallergic and antiemetic drugs	0.275	0.725	0.000
T45.9 Primarily systemic and haematological agent, unspecified	0.265	0.735	0.000
T45.8 Other primarily systemic and haematological agents	0.265	0.735	0.000
T45.7 Anticoagulant antagonists, vitamin K and other coagulants	0.265	0.735	0.000
T45.6 Fibrinolysis-affecting drugs	0.265	0.735	0.000
T45.4 Iron and its compounds	0.265	0.735	0.000
T45.3 Enzymes, not elsewhere classified	0.265	0.735	0.000
T45.5 Anticoagulants	0.223	0.777	0.001
T45.2 Vitamins, not elsewhere classified	0.221	0.778	0.001
T45.1 Antineoplastic and immunosuppressive drugs	0.173	0.826	0.001
C56 Malignant neoplasm of ovary	0.061	0.939	0.000
I60.9 Subarachnoid haemorrhage, unspecified	0.032	0.968	0.000
I60.2 Subarachnoid haemorrhage from anterior communicating artery	0.029	0.971	0.000
N92.3 Ovulation bleeding	0.028	0.972	0.000
I60 Subarachnoid haemorrhage	0.028	0.972	0.000
N87.0 Mild cervical dysplasia	0.027	0.973	0.000
Z31.0 Tuboplasty or vasoplasty after previous sterilisation	0.022	0.978	0.000
I60.3 Subarachnoid haemorrhage from posterior communicating artery	0.021	0.979	0.000
I60.0 Subarachnoid haemorrhage from carotid siphon and bifurcation	0.021	0.979	0.000
I60.1 Subarachnoid haemorrhage from middle cerebral artery	0.021	0.979	0.000
I60.4 Subarachnoid haemorrhage from basilar artery	0.020	0.979	0.000
I60.7 Subarachnoid haemorrhage from intracranial artery, unspecified	0.020	0.980	0.000
I60.5 Subarachnoid haemorrhage from vertebral artery	0.020	0.980	0.000
I60.6 Subarachnoid haemorrhage from other intracranial arteries	0.018	0.982	0.000
N87 Dysplasia of cervix uteri	0.018	0.982	0.000
N92.6 Irregular menstruation, unspecified	0.017	0.983	0.000
Z31 Procreative management	0.017	0.983	0.000
N92 Excessive, frequent and irregular menstruation	0.017	0.983	0.000
N87.2 Severe cervical dysplasia, not elsewhere classified	0.016	0.984	0.000
N87.1 Moderate cervical dysplasia	0.016	0.984	0.000
I60.8 Other subarachnoid haemorrhage	0.016	0.984	0.000
Z31.4 Procreative investigation and testing	0.016	0.984	0.000
N92.4 Excessive bleeding in the premenopausal period	0.015	0.985	0.000
Z31.8 Other procreative management	0.013	0.987	0.000
Z31.9 Procreative management, unspecified	0.013	0.987	0.000
Z31.6 General counselling and advice on procreation	0.012	0.988	0.000
Z31.5 Genetic counselling	0.012	0.988	0.000
Z31.3 Other assisted fertilisation methods	0.012	0.988	0.000
Z31.1 Artifical insemination	0.012	0.988	0.000
N92.2 Excessive menstruation at puberty	0.012	0.988	0.000
C15.5 Lower third of oesophagus	0.000	0.989	0.011
N92.5 Other specified irregular menstruation	0.010	0.990	0.000
Z31.2 In vitro fertilisation	0.010	0.990	0.000
C51-C58 Malignant neoplasms of female genital organs	0.009	0.991	0.000
C52 Malignant neoplasm of vagina	0.008	0.992	0.000
N92.1 Excessive and frequent menstruation with irregular cycle	0.008	0.992	0.000
C51 Malignant neoplasm of vulva	0.007	0.993	0.000
C58 Malignant neoplasm of placenta	0.007	0.993	0.000
C67.4 Posterior wall of bladder	0.007	0.993	0.000
C57 Malignant neoplasm of other and unspecified female genital organs	0.006	0.993	0.000
C53 Malignant neoplasm of cervix uteri	0.006	0.993	0.000
C67 Malignant neoplasm of bladder	0.007	0.993	0.000
N80.0 Endometriosis of uterus	0.006	0.994	0.000
C67.9 Bladder, unspecified	0.006	0.994	0.000
C67.6 Ureteric orifice	0.006	0.994	0.000
C51.0 Labium majus	0.006	0.994	0.000
C44.3 Skin of other and unspecified parts of face	0.000	0.994	0.006
C15 Malignant neoplasm of oesophagus	0.000	0.994	0.006
C15.4 Middle third of oesophagus	0.000	0.994	0.006
C51.8 Overlapping lesion of vulva	0.005	0.995	0.000
C51.2 Clitoris	0.005	0.995	0.000
C51.1 Labium minus	0.005	0.995	0.000
Z57.2 Occupational exposure to dust	0.005	0.995	0.000
C67.0 Trigone of bladder	0.005	0.995	0.000
N80 Endometriosis	0.005	0.995	0.000
K85.9 Acute pancreatitis, unspecified	0.000	0.995	0.005
R25.1 Tremor, unspecified	0.000	0.995	0.005
C67.8 Overlapping lesion of bladder	0.005	0.995	0.000
N87.9 Dysplasia of cervix uteri, unspecified	0.005	0.995	0.000
C48.2 Peritoneum, unspecified	0.005	0.995	0.000
I61.9 Intracerebral haemorrhage, unspecified	0.005	0.995	0.000
N76.0 Acute vaginitis	0.005	0.995	0.000
N72 Inflammatory disease of cervix uteri	0.005	0.995	0.000
C67.1 Dome of bladder	0.005	0.995	0.000
G61.0 Guillain-Barre syndrome	0.005	0.995	0.000
C57.8 Overlapping lesion of female genital organs	0.005	0.995	0.000
C57.7 Other specified female genital organs	0.005	0.995	0.000
C57.4 Uterine adnexa, unspecified	0.005	0.995	0.000
C57.3 Parametrium	0.005	0.995	0.000
C57.2 Round ligament	0.005	0.995	0.000
C57.1 Broad ligament	0.005	0.995	0.000
C53.8 Overlapping lesion of cervix uteri	0.005	0.995	0.000
C53.1 Exocervix	0.005	0.995	0.000
C67.7 Urachus	0.005	0.995	0.000
C51.9 Vulva, unspecified	0.005	0.995	0.000
C53.9 Cervix uteri, unspecified	0.005	0.995	0.000
I61 Intracerebral haemorrhage	0.005	0.995	0.000
C57.9 Female genital organ, unspecified	0.005	0.995	0.000
K65.0 Acute peritonitis	0.005	0.995	0.000
C67.3 Anterior wall of bladder	0.005	0.995	0.000
M23.81 Other internal derangements of knee (Anterior cruciate ligament or Anterior horn of medial meniscus)	0.000	0.995	0.005
C57.0 Fallopian tube	0.005	0.995	0.000
I47.9 Paroxysmal tachycardia, unspecified	0.000	0.995	0.005
N86 Erosion and ectropion of cervix uteri	0.005	0.995	0.000
D68.2 Hereditary deficiency of other clotting factors	0.000	0.995	0.005
N80-N98 Noninflammatory disorders of female genital tract	0.005	0.995	0.000
N80.2 Endometriosis of Fallopian tube	0.005	0.995	0.000
N80.3 Endometriosis of pelvic peritoneum	0.005	0.995	0.000
K27.9 Unspecified as acute or chronic, without haemorrhage or perforation	0.005	0.995	0.000
C15.8 Overlapping lesion of oesophagus	0.000	0.995	0.004
C15.2 Abdominal part of oesophagus	0.000	0.995	0.004
C15.0 Cervical part of oesophagus	0.000	0.995	0.004
C67.5 Bladder neck	0.004	0.995	0.000
I61.5 Intracerebral haemorrhage, intraventricular	0.004	0.995	0.000
N88.9 Noninflammatory disorder of cervix uteri, unspecified	0.005	0.995	0.000
C53.0 Endocervix	0.004	0.996	0.000
C67.2 Lateral wall of bladder	0.004	0.996	0.000
Z92.6 Personal history of chemotherapy for neoplastic disease	0.004	0.996	0.000
M23.8 Other internal derangements of knee	0.000	0.996	0.004
C55 Malignant neoplasm of uterus, part unspecified	0.004	0.996	0.000
C15.9 Oesophagus, unspecified	0.000	0.996	0.004
M23.83 Other internal derangements of knee (Medial collateral ligament or Other and unspecified medial meniscus)	0.000	0.996	0.004
M23.82 Other internal derangements of knee (Posterior cruciate ligament or Posterior horn of medial meniscus)	0.000	0.996	0.004
I61.1 Intracerebral haemorrhage in hemisphere, cortical	0.004	0.996	0.000
M23.80 Other internal derangements of knee (Multiple sites)	0.000	0.996	0.004
I61.3 Intracerebral haemorrhage in brain stem	0.004	0.996	0.000
N80.8 Other endometriosis	0.004	0.996	0.000
S20.0 Contusion of breast	0.004	0.996	0.000
N80.5 Endometriosis of intestine	0.004	0.996	0.000
C15.1 Thoracic part of oesophagus	0.000	0.996	0.004
I61.2 Intracerebral haemorrhage in hemisphere, unspecified	0.004	0.996	0.000
N80.6 Endometriosis in cutaneous scar	0.004	0.996	0.000
S20.2 Contusion of thorax	0.004	0.996	0.000
N89 Other noninflammatory disorders of vagina	0.004	0.996	0.000
C15.3 Upper third of oesophagus	0.000	0.996	0.004
K41.3 Unilateral or unspecified femoral hernia, with obstruction, without gangrene	0.000	0.996	0.004
I61.0 Intracerebral haemorrhage in hemisphere, subcortical	0.004	0.996	0.000
Z32.1 Pregnancy confirmed	0.004	0.996	0.000
N88 Other noninflammatory disorders of cervix uteri	0.004	0.996	0.000
I81 Portal vein thrombosis	0.004	0.996	0.000
S20 Superficial injury of thorax	0.004	0.996	0.000
K41.9 Unilateral or unspecified femoral hernia, without obstruction or gangrene	0.000	0.996	0.004
N89.5 Stricture and atresia of vagina	0.004	0.996	0.000
I60-I69 Cerebrovascular diseases	0.004	0.996	0.000
D68.6 Other Thrombophilia	0.000	0.996	0.004
I61.6 Intracerebral haemorrhage, multiple localised	0.004	0.996	0.000
Z57 Occupational exposure to risk-factors	0.004	0.996	0.000
D23.2 Skin of ear and external auricular canal	0.004	0.996	0.000
C48 Malignant neoplasm of retroperitoneum and peritoneum	0.004	0.996	0.000
D68 Other coagulation defects	0.000	0.996	0.004
N98 Complications associated with artificial fertilisation	0.003	0.997	0.000
N91 Absent, scanty and rare menstruation	0.003	0.997	0.000
M23.87 Other internal derangements of knee (Capsular ligament)	0.000	0.997	0.003
M23.85 Other internal derangements of knee (Posterior horn of lateral meniscus)	0.000	0.997	0.003
M23.84 Other internal derangements of knee (Lateral collateral ligament or Anterior horn of lateral meniscus)	0.000	0.997	0.003
N88.0 Leukoplakia of cervix uteri	0.003	0.997	0.000
Z57.3 Occupational exposure to other air contaminants	0.003	0.997	0.000
I66 Occlusion and stenosis of cerebral arteries, not resulting in cerebral infarction	0.003	0.997	0.000
D68.3 Haemorrhagic disorder due to circulating anticoagulants	0.000	0.997	0.003
I61.8 Other intracerebral haemorrhage	0.003	0.997	0.000
N84 Polyp of female genital tract	0.003	0.997	0.000
N80.4 Endometriosis of rectovaginal septum and vagina	0.003	0.997	0.000
N83.0 Follicular cyst of ovary	0.003	0.997	0.000
N97 Female infertility	0.003	0.997	0.000
N82 Fistulae involving female genital tract	0.003	0.997	0.000
N89.6 Tight hymenal ring	0.003	0.997	0.000
N89.0 Mild vaginal dysplasia	0.003	0.997	0.000
N83 Noninflammatory disorders of ovary, Fallopian tube and broad ligament	0.003	0.997	0.000
C48.1 Specified parts of peritoneum	0.003	0.997	0.000
I61.4 Intracerebral haemorrhage in cerebellum	0.003	0.997	0.000
S20.4 Other superficial injuries of back wall of thorax	0.003	0.997	0.000
I66.9 Occlusion and stenosis of unspecified cerebral artery	0.003	0.997	0.000
O64.0 Obstructed labour due to incomplete rotation of foetal head	0.003	0.997	0.000
C48.0 Retroperitoneum	0.003	0.997	0.000
H43.2 Crystalline deposits in vitreous body	0.003	0.997	0.000
K41 Femoral hernia	0.000	0.997	0.003
N89.7 Haematocolpos	0.003	0.997	0.000
N89.4 Leukoplakia of vagina	0.003	0.997	0.000
N89.3 Dysplasia of vagina, unspecified	0.003	0.997	0.000
N89.2 Severe vaginal dysplasia, not elsewhere classified	0.003	0.997	0.000
N89.1 Moderate vaginal dysplasia	0.003	0.997	0.000
N96 Habitual aborter	0.003	0.997	0.000
S20.1 Other and unspecified superficial injuries of breast	0.003	0.997	0.000
Z75.3 Unavailability and inaccessibility of health-care facilities	0.003	0.997	0.000
N88.3 Incompetence of cervix uteri	0.003	0.997	0.000
I66.3 Occlusion and stenosis of cerebellar arteries	0.003	0.997	0.000
D68.9 Coagulation defect, unspecified	0.000	0.997	0.003
J92.9 Pleural plaque without asbestos	0.000	0.997	0.003
N84.2 Polyp of vagina	0.003	0.997	0.000
S20.3 Other superficial injuries of front wall of thorax	0.003	0.997	0.000
T79.3 Post-traumatic wound infection, not elsewhere classified	0.003	0.997	0.000
M23.86 Other internal derangements of knee (Other and unspecified lateral meniscus)	0.000	0.997	0.003
M23.49 Loose body in knee-Unspec lig/men	0.000	0.997	0.003
I80.2 Phlebitis and thrombophlebitis of other deep vessels of lower extremities	0.000	0.997	0.003
N88.4 Hypertrophic elongation of cervix uteri	0.003	0.997	0.000
N88.1 Old laceration of cervix uteri	0.003	0.997	0.000
R68.0 Hypothermia, not associated with low environmental temperature	0.000	0.997	0.003
S20.7 Multiple superficial injuries of thorax	0.003	0.997	0.000
N83.9 Noninflammatory disorder of ovary, Fallopian tube and broad ligament, unspecified	0.003	0.997	0.000
C21.0 Anus, unspecified	0.003	0.997	0.000
N91.1 Secondary amenorrhoea	0.003	0.997	0.000
K85 Acute pancreatitis	0.000	0.997	0.003
D68.1 Hereditary factor XI deficiency	0.000	0.997	0.003
M22.2 Patellofemoral disorders	0.000	0.997	0.003
N84.1 Polyp of cervix uteri	0.003	0.997	0.000
O47.1 False labour at or after 37 completed weeks of gestation	0.003	0.997	0.000
Z57.9 Occupational exposure to unspecified risk-factor	0.003	0.997	0.000
Z57.7 Occupational exposure to vibration	0.003	0.997	0.000
Z57.6 Occupational exposure to extreme temperature	0.003	0.997	0.000
Z57.4 Occupational exposure to toxic agents in agriculture	0.003	0.997	0.000
Z57.1 Occupational exposure to radiation	0.003	0.997	0.000
Z57.0 Occupational exposure to noise	0.003	0.997	0.000
H35.4 Peripheral retinal degeneration	0.003	0.997	0.000
N83.1 Corpus luteum cyst	0.003	0.997	0.000
E10.1 With ketoacidosis	0.000	0.997	0.003
H02.4 Ptosis of eyelid	0.003	0.997	0.000
C48.8 Overlapping lesion of retroperitoneum and peritoneum	0.003	0.997	0.000
N84.0 Polyp of corpus uteri	0.003	0.997	0.000
N82.8 Other female genital tract fistulae	0.003	0.997	0.000
I68 Cerebrovascular disorders in diseases classified elsewhere	0.003	0.997	0.000
N82.0 Vesicovaginal fistula	0.003	0.997	0.000
N91.5 Oligomenorrhoea, unspecified	0.003	0.997	0.000
N97.9 Female infertility, unspecified	0.003	0.997	0.000
C54 Malignant neoplasm of corpus uteri	0.003	0.997	0.000
Z71.1 Person with feared complaint in whom no diagnosis is made	0.000	0.997	0.003
I66.8 Occlusion and stenosis of other cerebral artery	0.003	0.997	0.000
I66.2 Occlusion and stenosis of posterior cerebral artery	0.003	0.997	0.000
I66.1 Occlusion and stenosis of anterior cerebral artery	0.003	0.997	0.000
I66.0 Occlusion and stenosis of middle cerebral artery	0.003	0.997	0.000
N89.9 Noninflammatory disorder of vagina, unspecified	0.003	0.997	0.000
N91.4 Secondary oligomenorrhoea	0.003	0.997	0.000
N91.3 Primary oligomenorrhoea	0.003	0.997	0.000
N91.0 Primary amenorrhoea	0.003	0.997	0.000
N97.8 Female infertility of other origin	0.003	0.997	0.000
N98.9 Complication associated with artificial fertilisation, unspecified	0.003	0.997	0.000
N98.8 Other complications associated with artificial fertilisation	0.003	0.997	0.000
N98.3 Complications of attempted introduction of embryo in embryo transfer	0.003	0.997	0.000
N98.2 Complications of attempted introduction of fertilised ovum following in vitro fertilisation	0.003	0.997	0.000
N98.0 Infection associated with artificial insemination	0.003	0.997	0.000
M23.89 Other internal derangements of knee (Unspecified ligament or Unspecified meniscus)	0.000	0.997	0.003
X60.8 Other specified place	0.003	0.997	0.000
D68.4 Acquired coagulation factor deficiency	0.000	0.997	0.003
N89.8 Other specified noninflammatory disorders of vagina	0.003	0.997	0.000
D68.0 Von Willebrand's disease	0.000	0.997	0.003
M47.92 Spondylosis, unspecified (Cervical region)	0.003	0.997	0.000
K85.8 Other acute pancreatitis	0.000	0.997	0.003
N97.4 Female infertility associated with male factors	0.003	0.997	0.000
N97.3 Female infertility of cervical origin	0.003	0.997	0.000
N97.2 Female infertility of uterine origin	0.003	0.997	0.000
N97.0 Female infertility associated with anovulation	0.003	0.997	0.000
Z57.5 Occupational exposure to toxic agents in other industries	0.003	0.997	0.000
N82.2 Fistula of vagina to small intestine	0.002	0.997	0.000
M81.98 Osteoporosis, unspecified (Other)	0.003	0.997	0.000
S20.8 Superficial injuries of other and unspecified parts of thorax	0.003	0.997	0.000
I47 Paroxysmal tachycardia	0.000	0.997	0.003
N82.5 Female genital tract-skin fistulae	0.002	0.997	0.000
N80.9 Endometriosis, unspecified	0.003	0.997	0.000
N83.7 Haematoma of broad ligament	0.002	0.997	0.000
N83.4 Prolapse and hernia of ovary and Fallopian tube	0.002	0.997	0.000
N82.9 Female genital tract fistula, unspecified	0.002	0.997	0.000
S80.0 Contusion of knee	0.000	0.997	0.003
N82.1 Other female urinary-genital tract fistulae	0.002	0.997	0.000
N98.1 Hyperstimulation of ovaries	0.002	0.997	0.000
N80.1 Endometriosis of ovary	0.003	0.997	0.000
N84.9 Polyp of female genital tract, unspecified	0.002	0.997	0.000
K41.4 Unilateral or unspecified femoral hernia, with gangrene	0.000	0.997	0.002
K41.2 Bilateral femoral hernia, without obstruction or gangrene	0.000	0.997	0.002
K41.1 Bilateral femoral hernia, with gangrene	0.000	0.997	0.002
K41.0 Bilateral femoral hernia, with obstruction, without gangrene	0.000	0.997	0.002
I66.4 Occlusion and stenosis of multiple and bilateral cerebral arteries	0.002	0.997	0.000
N82.4 Other female intestinal-genital tract fistulae	0.002	0.997	0.000
K14.9 Disease of tongue, unspecified	0.003	0.997	0.000
D68.8 Other specified coagulation defects	0.000	0.998	0.002
Z57.8 Occupational exposure to other risk-factors	0.002	0.998	0.000
N83.8 Other noninflammatory disorders of ovary, Fallopian tube and broad ligament	0.002	0.998	0.000
N84.8 Polyp of other parts of female genital tract	0.002	0.998	0.000
K85.1 Biliary acute pancreatitis	0.000	0.998	0.002
K27 Peptic ulcer, site unspecified	0.002	0.998	0.000
I47.0 Reentry ventricular arrhythmia	0.000	0.998	0.002
K85.0 Idiopathic acute pancreatitis	0.000	0.998	0.002
N73.9 Female pelvic inflammatory disease, unspecified	0.002	0.998	0.000
H43 Disorders of vitreous body	0.002	0.998	0.000
H43.8 Other disorders of vitreous body	0.002	0.998	0.000
K85.3 Drug-induced acute pancreatitis	0.000	0.998	0.002
N83.6 Haematosalpinx	0.002	0.998	0.000
Z58 Problems related to physical environment	0.002	0.998	0.000
N76 Other inflammation of vagina and vulva	0.002	0.998	0.000
I68.8 Other cerebrovascular disorders in diseases classified elsewhere	0.002	0.998	0.000
I68.2 Cerebral arteritis in other diseases classified elsewhere	0.002	0.998	0.000
I68.1 Cerebral arteritis in infectious and parasitic diseases classified elsewhere	0.002	0.998	0.000
N91.2 Amenorrhoea, unspecified	0.002	0.998	0.000
G61 Inflammatory polyneuropathy	0.002	0.998	0.000
C54.8 Overlapping lesion of corpus uteri	0.002	0.998	0.000
C54.3 Fundus uteri	0.002	0.998	0.000
C54.2 Myometrium	0.002	0.998	0.000
C54.0 Isthmus uteri	0.002	0.998	0.000
I67.8 Other specified cerebrovascular diseases	0.002	0.998	0.000
K27.4 Chronic or unspecified with haemorrhage	0.002	0.998	0.000
Z58.1 Exposure to air pollution	0.002	0.998	0.000
I67 Other cerebrovascular diseases	0.002	0.998	0.000
Z58.8 Other problems related to physical environment	0.002	0.998	0.000
N73 Other female pelvic inflammatory diseases	0.002	0.998	0.000
I42.2 Other hypertrophic cardiomyopathy	0.000	0.998	0.002
K73.9 Chronic hepatitis, unspecified	0.000	0.998	0.002
D68.5 Primary Thrombophilia	0.000	0.998	0.002
I42.0 Dilated cardiomyopathy	0.000	0.998	0.002
N82.3 Fistula of vagina to large intestine	0.002	0.998	0.000
N70-N77 Inflammatory diseases of female pelvic organs	0.002	0.998	0.000
M21.57 Acquired clawhand, clubhand, clawfoot and clubfoot (Ankle and foot)	0.000	0.998	0.002
N76.4 Abscess of vulva	0.002	0.998	0.000
I68.0 Cerebral amyloid angiopathy	0.002	0.998	0.000
N03.9 Unspecified	0.002	0.998	0.000
H43.9 Disorder of vitreous body, unspecified	0.002	0.998	0.000
H43.0 Vitreous prolapse	0.002	0.998	0.000
N73.8 Other specified female pelvic inflammatory diseases	0.002	0.998	0.000
M47.12 Other spondylosis with myelopathy (Cervical region)	0.002	0.998	0.000
E61.1 Iron deficiency	0.000	0.998	0.002
I47.1 Supraventricular tachycardia	0.000	0.998	0.002
S82.60 Fracture of lateral malleolus (closed)	0.002	0.998	0.000
K86.1 Other chronic pancreatitis	0.000	0.998	0.002
H43.1 Vitreous haemorrhage	0.002	0.998	0.000
I47.2 Ventricular tachycardia	0.000	0.998	0.002
Z55-Z65 Persons with potential health hazards related to socioeconomic and psychosocial circumstances	0.002	0.998	0.000
O47.9 False labour, unspecified	0.002	0.998	0.000
Z58.5 Exposure to other pollution	0.002	0.998	0.000
C21.1 Anal canal	0.002	0.998	0.000
G61.9 Inflammatory polyneuropathy, unspecified	0.002	0.998	0.000
N76.1 Subacute and chronic vaginitis	0.002	0.998	0.000
S80.9 Superficial injury of lower leg, unspecified	0.000	0.998	0.002
R68 Other general symptoms and signs	0.000	0.998	0.002
R68.8 Other specified general symptoms and signs	0.000	0.998	0.002
I97.8 Other postprocedural disorders of circulatory system, not elsewhere classified	0.002	0.998	0.000
K27.6 Chronic or unspecified with both haemorrhage and perforation	0.002	0.998	0.000
K27.5 Chronic or unspecified with perforation	0.002	0.998	0.000
K27.2 Acute with both haemorrhage and perforation	0.002	0.998	0.000
K27.1 Acute with perforation	0.002	0.998	0.000
K27.0 Acute with haemorrhage	0.002	0.998	0.000
N73.0 Acute parametritis and pelvic cellulitis	0.002	0.998	0.000
N97.1 Female infertility of tubal origin	0.002	0.998	0.000
K85.2 Alcohol-induced acute pancreatitis	0.000	0.998	0.002
Z63.5 Disruption of family by separation and divorce	0.002	0.998	0.000
Z71.8 Other specified counselling	0.000	0.998	0.002
Z58.9 Problem related to physical environment, unspecified	0.002	0.998	0.000
Z58.6 Inadequate drinking-water supply	0.002	0.998	0.000
Z58.4 Exposure to radiation	0.002	0.998	0.000
Z58.3 Exposure to soil pollution	0.002	0.998	0.000
Z58.2 Exposure to water pollution	0.002	0.998	0.000
Z58.0 Exposure to noise	0.002	0.998	0.000
I62 Other nontraumatic intracranial haemorrhage	0.002	0.998	0.000
Z32 Pregnancy examination and test	0.002	0.998	0.000
K27.3 Acute without haemorrhage or perforation	0.002	0.998	0.000
K86.3 Pseudocyst of pancreas	0.000	0.998	0.002
N64.1 Fat necrosis of breast	0.002	0.998	0.000
N73.1 Chronic parametritis and pelvic cellulitis	0.002	0.998	0.000
R68.3 Clubbing of fingers	0.000	0.998	0.002
Z80.1 Family history of malignant neoplasm of trachea, bronchus and lung	0.000	0.998	0.002
S80 Superficial injury of lower leg	0.000	0.998	0.002
I42.1 Obstructive hypertrophic cardiomyopathy	0.000	0.998	0.002
K27.7 Chronic without haemorrhage or perforation	0.002	0.998	0.000
Z63 Other problems related to primary support group, including family circumstances	0.002	0.998	0.000
G61.1 Serum neuropathy	0.002	0.998	0.000
I64 Stroke, not specified as haemorrhage or infarction	0.002	0.998	0.000
I67.6 Nonpyogenic thrombosis of intracranial venous system	0.002	0.998	0.000
I67.5 Moyamoya disease	0.002	0.998	0.000
I67.4 Hypertensive encephalopathy	0.002	0.998	0.000
I67.3 Progressive vascular leukoencephalopathy	0.002	0.998	0.000
J15.1 Pneumonia due to Pseudomonas	0.000	0.998	0.002

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations